glp-1 clinical trials sign up We are now enrolling for a new study with fewer reported side effects than others in its class. If you have ever considered trying a GLP-1, this study may be a Two Pediatric MASLD Publications: Call

In 2025, CMS signaled it would allow Medicare Part D and Medicare Advantage plans to optionally cover GLP-1 medications approved for cardiovascular risk reduction which includes semaglutide

Medicaid Spending on GLP-1 Drugs by State Data Source: IRIS by Real Chemistry | Image Credit: Real Chemistry Nationally, Medicaid spending on GLP-1s totaled $3.5 billion between November 2023 and October 2024, averaging $48 per Medicaid enrollee

This guide covers what actually changes hormonally after 40, how GLP-1s help (and what they dont do), realistic results and timelines, side effects women need to watch for, and the non-negotiable lifestyle factors that determine whether you end up looking lean and strong or just smaller and weaker

Understanding those effects could help guide how we approach prevention and treatment of AFib in the future. This single-center, retrospective study looked at 13,034 patients who initiated GLP-1-RA therapy between January 2020 and May 2024

12 These effects could be secondary to reduced hepatic lipogenesis, increased fatty acid oxidation and modulation of lipoprotein metabolism